PTPN11 and central nervous system cancer: SHP-2 encodes a phosphotyrosine phosphatase that mediates the propagation of Ras/Raf/MAPK growth signaling; inhibition of SHP-2 has been shown to impair glioma tumorigenesis [48, 49].